Impact of direct-acting antiviral (DAA) treatment for hepatitis C on pulmonary hemodynamics

被引：0
|
作者：
Orizaga Franco, Tanya Elisa [1 ]
Blanco Vich, Isabel [2 ,3 ]
Slens, Sabela [4 ,5 ,6 ]
Alvarado, Edilmar [7 ]
Marino, Zoe [4 ,5 ,6 ]
Torras, Xavier [7 ]
Baiges, Anna [4 ,5 ,6 ]
Turon, Fanny [4 ,5 ,6 ]
Hernandez-Gea, Virginia [4 ,5 ,6 ]
Villanueva, Candid [7 ]
Moises, Jorge [1 ]
Forns, Xavier [4 ,5 ,6 ]
Carles Garcia-Pagan, Joan [4 ,5 ,6 ]
Barbera Mir, Joan Albert [1 ,2 ,3 ]
机构：
[1] Univ Barcelona, Hosp Clin IDIBAPS, Dept Pulm Med, Barcelona, Spain
[2] Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
[3] Biomed Res Networking Ctr Resp Dis CIBERES, Barcelona, Spain
[4] Univ Barcelona, Hosp Clin IDIBAPS, Hepatol Serv, Barcelona, Spain
[5] Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Madrid, Spain
[6] Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Barcelona, Spain
[7] Hosp Santa Creu & Sant Pau, Digest Syst Serv, Barcelona, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Adults; Pulmonary hypertension; Circulation;
D O I：
10.1183/13993003.congress-2020.1476
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1476
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Direct-acting antiviral treatment for hepatitis C
    Holmes, Jacinta A.
    Rutledge, Stephanie M.
    Chung, Raymond T.
    LANCET, 2019, 393 (10179): : 1392 - 1394
  • [2] Interferon-free direct-acting antiviral (DAA) regimens for treatment of chronic hepatitis C
    Kowdley, K.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 9 - 9
  • [3] Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections
    Izhari, Mohammad Asrar
    DIAGNOSTICS, 2023, 13 (19)
  • [4] Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers
    Lam, Laurent
    Fontaine, Helene
    Lapidus, Nathanael
    Dorival, Celine
    Bellet, Jonathan
    Larrey, Dominique
    Nahon, Pierre
    Diallo, Alpha
    Cagnot, Carole
    Lusivka-Nzinga, Clovis
    Teoule, Francois
    Hejblum, Gilles
    Bourliere, Marc
    Pol, Stanislas
    Carrat, Fabrice
    JOURNAL OF HEPATOLOGY, 2022, 77 : S17 - S18
  • [5] The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C
    Sacco, Marco
    Saracco, Giorgio M.
    MINERVA GASTROENTEROLOGY, 2021, 67 (03): : 264 - 272
  • [6] Impact of direct-acting antiviral treatment of hepatitis C on the quality of life of adults in Ukraine
    M. Benade
    S. Rosen
    S. Antoniak
    C. Chasela
    Y. Stopolianska
    T. Barnard
    M. M. Gandhi
    I. Ivanchuk
    V. Tretiakov
    J. Dible
    T. Minior
    K. W. Chew
    C. van der Horst
    Z. Tsenilova
    I. Sanne
    BMC Infectious Diseases, 22
  • [7] Impact of direct-acting antiviral treatment of hepatitis C on the quality of life of adults in Ukraine
    Benade, M.
    Rosen, S.
    Antoniak, S.
    Chasela, C.
    Stopolianska, Y.
    Barnard, T.
    Gandhi, M. M.
    Ivanchuk, I.
    Tretiakov, V
    Dible, J.
    Minior, T.
    Chew, K. W.
    van der Horst, C.
    Tsenilova, Z.
    Sanne, I
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [8] Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers
    Lam, Laurent
    Fontaine, Helene
    Lapidus, Nathanael
    Dorival, Celine
    Bellet, Jonathan
    Larrey, Dominique
    Nahon, Pierre
    Diallo, Alpha
    Cagnot, Carole
    Lusivika-Nzinga, Clovis
    Teoule, Francois
    Hejblum, Gilles
    Bourliere, Marc
    Pol, Stanislas
    Carrat, Fabrice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (04) : 486 - 495
  • [9] Cost-effectiveness of a Perfect Direct-acting Antiviral Agent (DAA) in the treatment of chronic hepatitis C in Hong Kong
    Lo, Angeline Oi-Shan
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 379 - 379
  • [10] Barriers to Treatment of Hepatitis C Virus in the Direct-Acting Antiviral Era
    Ramers, Christian B.
    Liu, Jie
    Frenette, Catherine
    CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2019, 11 (02) : 92 - 102
12345